Dermatological and Wound Healing Research Advanced Skin Regeneration and Scar Reduction Research on individual components has shown significant effects on dermal wound healing with enhanced outcomes when anti-inflammatory control is included[14]
DSIP is not FDA-approved, not controlled in the US, and sits in a research-chemical gray area
The REDEFINE 1 Phase 3 trial extended this observation, showing 11.8% weight loss with cagrilintide 2.4 mg alone over 68 weeks
Combination Therapies Ongoing exploration pairs GHK-Cu with other regenerative peptides (such as BPC-157, TB-4, or GHK variants) to amplify tissue repair benefits.
Recently, it even managed to inhibit tumor growth and malignant cancer cells in mice
Ultimately, mastering the art of reconstitution is about more than just following steps